134 related articles for article (PubMed ID: 14689968)
1. Arsenic trioxide enhances radiation response of 9L glioma in the rat brain.
Kim JH; Lew YS; Kolozsvary A; Ryu S; Brown SL
Radiat Res; 2003 Dec; 160(6):662-6. PubMed ID: 14689968
[TBL] [Abstract][Full Text] [Related]
2. Intravenous administration of arsenic trioxide encapsulated in liposomes inhibits the growth of C6 gliomas in rat brains.
Zhao S; Zhang X; Zhang J; Zhang J; Zou H; Liu Y; Dong X; Sun X
J Chemother; 2008 Apr; 20(2):253-62. PubMed ID: 18467254
[TBL] [Abstract][Full Text] [Related]
3. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
4. A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas.
Kumthekar P; Grimm S; Chandler J; Mehta M; Marymont M; Levy R; Muro K; Helenowski I; McCarthy K; Fountas L; Raizer J
J Neurooncol; 2017 Jul; 133(3):589-594. PubMed ID: 28510787
[TBL] [Abstract][Full Text] [Related]
5. Optimization of combination therapy of arsenic trioxide and fractionated radiotherapy for malignant glioma.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):493-8. PubMed ID: 16563655
[TBL] [Abstract][Full Text] [Related]
6. Study of arsenic trioxide-induced vascular shutdown and enhancement with radiation in solid tumor.
Monzen H; Griffin RJ; Williams BW; Amano M; Ando S; Hasegawa T
Radiat Med; 2004; 22(4):205-11. PubMed ID: 15468939
[TBL] [Abstract][Full Text] [Related]
7. Synergistic therapeutic effect of arsenic trioxide and radiotherapy in BALB/C nude mice bearing nasopharyngeal carcinoma xenografts.
Xie LX; Lin XH; Li DR; Chen JY; Hong CQ; Du CW
Exp Oncol; 2007 Mar; 29(1):45-8. PubMed ID: 17431388
[TBL] [Abstract][Full Text] [Related]
8. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene.
Kim JH; Kolozsvary A; Rogulski K; Khil MS; Brown SL; Freytag SO
Cancer J Sci Am; 1998; 4(6):364-9. PubMed ID: 9853135
[TBL] [Abstract][Full Text] [Related]
9. [Experimental study of the anti-tumor effect of arsenic trioxide or thalidomide alone and combination of both for treatment of myelodysplastic syndrome model].
Lu J; Jin J; Xu WL
Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):228-33. PubMed ID: 16624066
[TBL] [Abstract][Full Text] [Related]
10. Synergistic interaction with arsenic trioxide and fractionated radiation in locally advanced murine tumor.
Lew YS; Kolozsvary A; Brown SL; Kim JH
Cancer Res; 2002 Aug; 62(15):4202-5. PubMed ID: 12154019
[TBL] [Abstract][Full Text] [Related]
11. Comparison of optical and power Doppler ultrasound imaging for non-invasive evaluation of arsenic trioxide as a vascular disrupting agent in tumors.
Alhasan MK; Liu L; Lewis MA; Magnusson J; Mason RP
PLoS One; 2012; 7(9):e46106. PubMed ID: 23029403
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic drugs synergize with a membrane macrophage colony-stimulating factor-based tumor vaccine to therapeutically treat rats with an established malignant intracranial glioma.
Jeffes EW; Zhang JG; Hoa N; Petkar A; Delgado C; Chong S; Obenaus A; Sanchez R; Khalaghizadeh S; Khomenko T; Knight BA; Alipanah R; Nguyen TV; Shah C; Vohra S; Zhuang JL; Liu J; Wepsic HT; Jadus MR
J Immunol; 2005 Mar; 174(5):2533-43. PubMed ID: 15728459
[TBL] [Abstract][Full Text] [Related]
13. Increased tumor cures using combined radiosurgery and BCNU in the treatment of 9l glioma in the rat brain.
Khil MS; Kolozsvary A; Apple M; Kim JH
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):511-6. PubMed ID: 10802380
[TBL] [Abstract][Full Text] [Related]
14. Additivity, antagonism, and synergy in arsenic trioxide-induced growth inhibition of C6 glioma cells: effects of genistein, quercetin and buthionine-sulfoximine.
Klauser E; Gülden M; Maser E; Seibert S; Seibert H
Food Chem Toxicol; 2014 May; 67():212-21. PubMed ID: 24632069
[TBL] [Abstract][Full Text] [Related]
15. Low-dose arsenic trioxide enhances 5-aminolevulinic acid-induced PpIX accumulation and efficacy of photodynamic therapy in human glioma.
Wang C; Chen X; Wu J; Liu H; Ji Z; Shi H; Gao C; Han D; Wang L; Liu Y; Yang G; Fu C; Li H; Zhang D; Liu Z; Li X; Yin F; Zhao S
J Photochem Photobiol B; 2013 Oct; 127():61-7. PubMed ID: 23962849
[TBL] [Abstract][Full Text] [Related]
16. A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood.
Cohen KJ; Gibbs IC; Fisher PG; Hayashi RJ; Macy ME; Gore L
Neuro Oncol; 2013 Jun; 15(6):783-7. PubMed ID: 23460318
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide in hematological malignancies: the new discovery of an ancient drug.
Bonati A; Rizzoli V; Lunghi P
Curr Pharm Biotechnol; 2006 Dec; 7(6):397-405. PubMed ID: 17168655
[TBL] [Abstract][Full Text] [Related]
18. Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors.
Griffin RJ; Lee SH; Rood KL; Stewart MJ; Lyons JC; Lew YS; Park H; Song CW
Neoplasia; 2000; 2(6):555-60. PubMed ID: 11228548
[TBL] [Abstract][Full Text] [Related]
19. Effect of arsenic trioxide on rat hepatocellular carcinoma and its renal cytotoxity.
Wang SS; Zhang T; Wang XL; Hong L; Qi QH
World J Gastroenterol; 2003 May; 9(5):930-5. PubMed ID: 12717832
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo effectiveness of arsenic trioxide against murine T-cell prolymphocytic leukaemia.
Récher C; Chopin M; Raffoux E; Pierron G; Poupon J; Sigaux F; Dombret H; Stern MH
Br J Haematol; 2002 May; 117(2):343-50. PubMed ID: 11972516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
